XOMA (XOMA) News Today $20.80 +0.52 (+2.56%) Closing price 04:00 PM EasternExtended Trading$20.81 +0.01 (+0.05%) As of 04:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period XOMA Royalty Completes Sale of Kinnate Pipeline AssetsApril 14 at 8:44 AM | gurufocus.comXOMA (XOMA) Sells Kinnate Biopharma Pipeline Assets for Potential $270M | XOMA Stock NewsApril 14 at 8:44 AM | gurufocus.comXOMA Royalty Completes Sale of Kinnate Pipeline Assets | XOMA Stock NewsApril 14 at 7:48 AM | gurufocus.comXOMA Royalty Completes Sale of Kinnate Pipeline AssetsApril 14 at 7:30 AM | globenewswire.comXOMA (NASDAQ:XOMA) Upgraded at StockNews.comApril 14 at 1:45 AM | americanbankingnews.comXOMA (NASDAQ:XOMA) Stock Rating Upgraded by StockNews.comStockNews.com raised shares of XOMA from a "sell" rating to a "hold" rating in a report on Friday.April 13 at 1:29 AM | marketbeat.comInsider Buying: XOMA Co. (NASDAQ:XOMA) CIO Purchases 2,000 Shares of StockApril 10, 2025 | insidertrades.comXOMA Royalty Corporation (XOMA): Among Stocks Insiders Bought in April After Trump’s Tariff RolloutApril 9, 2025 | msn.comJoseph M. Limber Buys 5,243 Shares of XOMA Co. (NASDAQ:XOMA) StockApril 9, 2025 | insidertrades.comInsider Buying: XOMA Co. (NASDAQ:XOMA) Director Acquires 5,243 Shares of StockXOMA Co. (NASDAQ:XOMA - Get Free Report) Director Joseph M. Limber acquired 5,243 shares of the stock in a transaction dated Monday, April 7th. The stock was acquired at an average cost of $25.60 per share, with a total value of $134,220.80. Following the transaction, the director now owns 10,000 shares of the company's stock, valued at approximately $256,000. This trade represents a 110.22 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website.April 9, 2025 | marketbeat.comXOMA Co. (NASDAQ:XOMA) Director Joseph M. Limber Buys 17,935 SharesXOMA Co. (NASDAQ:XOMA - Get Free Report) Director Joseph M. Limber bought 17,935 shares of the firm's stock in a transaction on Thursday, April 3rd. The shares were acquired at an average cost of $25.24 per share, with a total value of $452,679.40. Following the purchase, the director now directly owns 16,524 shares of the company's stock, valued at approximately $417,065.76. This represents a -1,271.08 % increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website.April 9, 2025 | marketbeat.comXOMA Royalty Corporation's Preferreds Still Offer Attractive Yields With A Biotech TwistApril 8, 2025 | seekingalpha.comXOMA (NASDAQ:XOMA) Cut to Sell at StockNews.comApril 6, 2025 | americanbankingnews.comXOMA (NASDAQ:XOMA) Rating Lowered to "Sell" at StockNews.comStockNews.com lowered XOMA from a "hold" rating to a "sell" rating in a report on Thursday.April 5, 2025 | marketbeat.comXOMA Royalty to Present at Jones Healthcare and Technology Innovation ConferenceApril 2, 2025 | globenewswire.comXOMA (NASDAQ:XOMA) Earns "Buy" Rating from HC WainwrightHC Wainwright reiterated a "buy" rating and set a $104.00 price objective on shares of XOMA in a research report on Friday.March 29, 2025 | marketbeat.comXOMA Co. (NASDAQ:XOMA) CIO Bradley Sitko Purchases 4,134 SharesXOMA Co. (NASDAQ:XOMA - Get Free Report) CIO Bradley Sitko acquired 4,134 shares of the company's stock in a transaction that occurred on Friday, March 21st. The stock was acquired at an average cost of $23.89 per share, for a total transaction of $98,761.26. Following the acquisition, the executive now owns 10,484 shares of the company's stock, valued at $250,462.76. The trade was a 65.10 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.March 26, 2025 | marketbeat.comBradley Sitko Acquires 4,134 Shares of XOMA Co. (NASDAQ:XOMA) StockMarch 26, 2025 | insidertrades.comHC Wainwright Comments on XOMA's Q1 Earnings (NASDAQ:XOMA)XOMA Co. (NASDAQ:XOMA - Free Report) - Equities research analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for XOMA in a report issued on Wednesday, March 19th. HC Wainwright analyst J. Pantginis forecasts that the biotechnology company will earn ($0.20) per shareMarch 22, 2025 | marketbeat.comLeerink Partnrs Issues Optimistic Forecast for XOMA EarningsXOMA Co. (NASDAQ:XOMA - Free Report) - Investment analysts at Leerink Partnrs boosted their FY2025 earnings estimates for XOMA in a research note issued on Tuesday, March 18th. Leerink Partnrs analyst D. Risinger now forecasts that the biotechnology company will post earnings per share of ($0.60)March 21, 2025 | marketbeat.comXOMA Preferred Shares Series A declares $0.539 dividendMarch 20, 2025 | seekingalpha.comXOMA Corp - 8.375% DP PFD B declares $0.5234 dividendMarch 20, 2025 | seekingalpha.comXOMA Royalty Declares Quarterly Preferred Stock DividendsMarch 20, 2025 | gurufocus.comXOMA's (XOMA) "Buy" Rating Reaffirmed at HC WainwrightHC Wainwright restated a "buy" rating and issued a $104.00 price target on shares of XOMA in a report on Wednesday.March 20, 2025 | marketbeat.comXOMA Royalty Declares Quarterly Preferred Stock DividendsMarch 20, 2025 | globenewswire.comLeerink Partnrs Estimates XOMA's Q1 Earnings (NASDAQ:XOMA)XOMA Co. (NASDAQ:XOMA - Free Report) - Stock analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for XOMA in a research report issued to clients and investors on Tuesday, March 18th. Leerink Partnrs analyst D. Risinger expects that the biotechnology company will poMarch 20, 2025 | marketbeat.comXOMA Royalty Full Year 2024 Earnings: EPS Misses ExpectationsMarch 19, 2025 | finance.yahoo.comXOMA Royalty Corp (XOMA) Reports Q4 EPS of -$0.30, Revenue of $8. ...March 19, 2025 | gurufocus.comXOMA (NASDAQ:XOMA) Releases Quarterly Earnings Results, Misses Expectations By $0.17 EPSXOMA (NASDAQ:XOMA - Get Free Report) issued its quarterly earnings data on Monday. The biotechnology company reported ($0.46) earnings per share for the quarter, missing the consensus estimate of ($0.29) by ($0.17). XOMA had a negative net margin of 151.34% and a negative return on equity of 24.95%.March 18, 2025 | marketbeat.comXOMA Royalty Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Business AchievementsMarch 17, 2025 | globenewswire.comXOMA (XOMA) to Release Earnings on FridayXOMA (NASDAQ:XOMA) will be releasing earnings before the market opens on Friday, March 14, Financial Modeling Prep reports.March 7, 2025 | marketbeat.comXOMA (NASDAQ:XOMA) Downgraded by StockNews.com to "Sell"StockNews.com downgraded shares of XOMA from a "hold" rating to a "sell" rating in a research note on Tuesday.February 26, 2025 | marketbeat.comLigand Leads $75 Million Royalty Financing in Castle Creek BiosciencesFebruary 25, 2025 | globenewswire.comXOMA Royalty to Present at Investor Conferences in MarchFebruary 24, 2025 | globenewswire.comAcuitas Investments LLC Has $1.60 Million Position in XOMA Co. (NASDAQ:XOMA)Acuitas Investments LLC lowered its stake in shares of XOMA Co. (NASDAQ:XOMA - Free Report) by 31.1% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 60,704 shares of the biotechnology company's stock after selling 27,354 sFebruary 18, 2025 | marketbeat.comXOMA (NASDAQ:XOMA) Upgraded by StockNews.com to Hold RatingStockNews.com upgraded shares of XOMA from a "sell" rating to a "hold" rating in a report on Tuesday.February 11, 2025 | marketbeat.comXOMA Royalty to Present at Oppenheimer 35th Annual Healthcare Life Sciences ConferenceFebruary 4, 2025 | globenewswire.comXOMA (NASDAQ:XOMA) Downgraded to Sell Rating by StockNews.comStockNews.com cut XOMA from a "hold" rating to a "sell" rating in a report on Monday.February 3, 2025 | marketbeat.comXOMA (NASDAQ:XOMA) Price Target Lowered to $104.00 at HC WainwrightHC Wainwright lowered their price target on XOMA from $123.00 to $104.00 and set a "buy" rating on the stock in a report on Monday.February 3, 2025 | marketbeat.comInsider Selling: XOMA Co. (NASDAQ:XOMA) Major Shareholder Sells 500,742 Shares of StockXOMA Co. (NASDAQ:XOMA - Get Free Report) major shareholder Bvf Partners L. P/Il sold 500,742 shares of the company's stock in a transaction on Friday, January 24th. The shares were sold at an average price of $26.10, for a total value of $13,069,366.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Major shareholders that own more than 10% of a company's shares are required to disclose their sales and purchases with the SEC.January 28, 2025 | marketbeat.comOptimistic Long-term Revenue Potential for Xoma Driven by Vabysmo Royalties and Market PerformanceJanuary 15, 2025 | markets.businessinsider.comXOMA Royalty Corporation: High-Risk Royalty Aggregator Best AvoidedJanuary 15, 2025 | seekingalpha.comBuy Rating for Xoma Driven by Promising Drug Advancements and Strong Partnership PipelineJanuary 8, 2025 | markets.businessinsider.comStockNews.com Downgrades XOMA (NASDAQ:XOMA) to SellStockNews.com lowered XOMA from a "hold" rating to a "sell" rating in a research note on Wednesday.January 8, 2025 | marketbeat.comHC Wainwright Reiterates "Buy" Rating for XOMA (NASDAQ:XOMA)HC Wainwright reiterated a "buy" rating and set a $123.00 target price on shares of XOMA in a research report on Tuesday.January 7, 2025 | marketbeat.comXOMA Corp - 8.375% DP PFD B goes ex dividend tomorrowJanuary 2, 2025 | msn.comXOMA Co. (NASDAQ:XOMA) Sees Significant Growth in Short InterestXOMA Co. (NASDAQ:XOMA - Get Free Report) was the target of a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 139,000 shares, a growth of 23.4% from the November 30th total of 112,600 shares. Based on an average daily volume of 29,100 shares, the short-interest ratio is presently 4.8 days.December 29, 2024 | marketbeat.comXOMA (NASDAQ:XOMA) Lowered to "Sell" Rating by StockNews.comStockNews.com downgraded XOMA from a "hold" rating to a "sell" rating in a research note on Friday.December 27, 2024 | marketbeat.comXOMA Corp - 8.375% DP PFD B declares $0.5234 dividendDecember 19, 2024 | seekingalpha.comXOMA Preferred Shares Series A declares $0.5391 dividendDecember 19, 2024 | seekingalpha.com Remove Ads Get XOMA News Delivered to You Automatically Sign up to receive the latest news and ratings for XOMA and its competitors with MarketBeat's FREE daily newsletter. Email Address XOMA Media Mentions By Week XOMA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XOMA News Sentiment▼0.950.80▲Average Medical News Sentiment XOMA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XOMA Articles This Week▼132▲XOMA Articles Average Week Remove Ads Get XOMA News Delivered to You Automatically Sign up to receive the latest news and ratings for XOMA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies OPKO Health News Geron News Myriad Genetics News Zenas Biopharma News Rigel Pharmaceuticals News Vanda Pharmaceuticals News Emergent BioSolutions News Verastem News Codexis News Sangamo Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XOMA) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XOMA Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share XOMA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy XOMA Stock Free XOMA Stock Alerts